🇺🇸 Insulatard, flexpen in United States

81 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Hypoglycaemia — 23 reports (28.4%)
  2. Dizziness — 7 reports (8.64%)
  3. Dyspnoea — 7 reports (8.64%)
  4. Malaise — 7 reports (8.64%)
  5. Nausea — 7 reports (8.64%)
  6. Fall — 6 reports (7.41%)
  7. Lactic Acidosis — 6 reports (7.41%)
  8. Loss Of Consciousness — 6 reports (7.41%)
  9. Premature Baby — 6 reports (7.41%)
  10. Vomiting — 6 reports (7.41%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is Insulatard, flexpen approved in United States?

Insulatard, flexpen does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Insulatard, flexpen in United States?

Göteborg University is the originator. The local marketing authorisation holder may differ — check the official source linked above.